Saudi Arabia joins International Agency for Research on Cancer

UF Health Cancer Center rolls out mobile cancer screening vehicle

UF Health officials and supporters gathered Wednesday to unveil the UF Health Cancer Center’s Mobile Cancer Screening Connector, which will take cancer screening care to a 23-county area in North Florida. UF Health photo by Nate GuidryThe University of Florida Health Cancer Center launched a 40-foot-long mobile cancer screening bus that will expand access to cancer screenings and essential health care services, including 3D mammograms and cervical, colon, and prostate cancer screenings.

November 01, 2024

Vol.50 No.41

Clinical

GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation

In an industry that set its sights on reshaping cancer detection, GRAIL Inc. had the appearance of a pioneer.

Tracing cancer back to birth uncovers promising biomarkers for prevention, early detection, targeted treatment of childhood leukemia

Molecular markers in blood at birth are linked to later development of acute lymphoblastic leukemia, the most common cancer type that affects children, according to a study published in Molecular Cancer.

October 25, 2024

Vol.50 No.40

In Brief

UCLA researchers receive $3M NIH grant for CRC screening follow-up in underserved communities

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center were awarded a $3 million grant from NIH to improve follow-up care for colorectal cancer screening in underserved populations.

October 04, 2024

Vol.50 No.37

Drugs & Targets

FDA approves Cologuard Plus Test for non-invasive CRC screening

FDA approved the Cologuard Plus test, a multitarget stool DNA test. The Cologuard Plus test is now approved for adults ages 45 and older who are at average risk for colorectal cancer.

October 04, 2024

Vol.50 No.37

Regulatory News

New FDA mandate to tell patients whether their breasts are “dense” or “not dense” baffles doctors
Problem: “Breast density is in the eye of the mammographer”

Collage art of mammograms of dense breastsIllustrator: Cyrus FineganWhile breast cancer experts are anything but clear on what the words “dense breasts” signify in the clinic, or for that matter, in the English language, FDA appears to be less perplexed.

September 27, 2024

Vol.50 No.36

By Claire Marie Porter

Saudi Arabia joins International Agency for Research on Cancer

YOU MAY BE INTERESTED IN

UF Health Cancer Center rolls out mobile cancer screening vehicle

GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation

Tracing cancer back to birth uncovers promising biomarkers for prevention, early detection, targeted treatment of childhood leukemia

UCLA researchers receive $3M NIH grant for CRC screening follow-up in underserved communities

FDA approves Cologuard Plus Test for non-invasive CRC screening

New FDA mandate to tell patients whether their breasts are “dense” or “not dense” baffles doctors
Problem: “Breast density is in the eye of the mammographer”

Renew today!

Subscriber content

Login

Saudi Arabia joins International Agency for Research on Cancer

YOU MAY BE INTERESTED IN

UF Health Cancer Center rolls out mobile cancer screening vehicle

GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation

Tracing cancer back to birth uncovers promising biomarkers for prevention, early detection, targeted treatment of childhood leukemia

UCLA researchers receive $3M NIH grant for CRC screening follow-up in underserved communities

FDA approves Cologuard Plus Test for non-invasive CRC screening

New FDA mandate to tell patients whether their breasts are “dense” or “not dense” baffles doctorsProblem: “Breast density is in the eye of the mammographer”

Login

New FDA mandate to tell patients whether their breasts are “dense” or “not dense” baffles doctors
Problem: “Breast density is in the eye of the mammographer”